It has been demonstrated that aberrant and strong nuclear expression of TFE3 is seen exclusively in tumours which contain the TFE3 gene fusions [11], such as ASPS and rare paediatric renal carcinomas [12]. Here, TFE3 is linked to alveolar soft part sarcoma.